Details concerning the Tolperisone Hydrochloride combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels ...

Details concerning the Tolperisone medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.

Tolperisone, a centrally-acting muscle relaxant, may treat symptoms of acute muscle spasms without the sleepiness and cognitive effects associated with other skeletal muscle relaxants, data from ...

The primary objective of the study was to assess the efficacy of various daily doses of tolperisone to determine the dose to be used for the planned Phase 3 clinical program. Overall, the STAR ...

The Drugs Controller General (India) has directed the State drug controllers to restrict the fixed dose combination (FDC) tolperisone HCI 150 mg+ paracetamol IP 500 mg tablet only for symptomatic ...

The agreement provides Katama the exclusive right to develop and market Sanochemia's proprietary tolperisone formulation in North America. Katama will initially develop tolperisone for the ...

The clinical trial is designed as a three-way cross-over study in healthy volunteers that includes tolperisone, placebo and the leading market-share product in the category, cyclobenzaprine ...

Wien (pta022/19.01.2017/11:09 UTC+1) Sanochemia announces advancement of Tolperisone's clinical development by Neurana Pharmaceuticals Inc. in the USA Vienna, January 19, 2017 - Sanochemia ...

According to Neurana, the clinical study of its compound, tolperisone, for the relief of muscle spasm associated with acute, painful musculoskeletal conditions, failed to meet its primary and key ...